The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPuma Vct 13 Plc Regulatory News (PU13)

Share Price Information for Puma Vct 13 Plc (PU13)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.50
Bid: 115.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 15.00 (13.043%)
Open: 122.50
High: 122.50
Low: 122.50
Prev. Close: 122.50
PU13 Live PriceLast checked at -
Puma VCT 13 is an Investment Trust

To produce regular tax-free income distributions from a portfolio of unquoted companies in the United Kingdom.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

28 Jun 2019 10:28

RNS Number : 8242D
Puma VCT 13 PLC
28 June 2019
 

HIGHLIGHTS

 

· Top-up Offer closed early having been over-subscribed

· Fund raising of just over £15.5m now completed

· Qualifying investments completed in four SMEs during the year, representing just under one third of the fund

 

 

CHAIRMAN'S STATEMENT

 

Introduction

 

I am pleased to present to you as Chairman the annual report for Puma VCT 13 plc for the year to 28 February 2019, which was the Company's first period of investment following closing of the first offer last summer. I am pleased to report that the fund raised just over £15.5 million over the two offers.

 

The Company began investing in the latter half of 2018 and has now deployed just under one third of available funds in qualifying investments.

 

The Investment Manager, Puma Investments, has over £150 million of money under management in this, other Puma VCTs and related EIS funds and a well-established, experienced VCT team to manage the Company's deal flow.

 

Investments

 

During the year, the Company completed a series of qualifying investments for a total of just over £4.5 million. At the end of the year, the Company had a total of £7.9 million invested - details of these investments can be found in the Investment Manager's report on pages 3 to 4.

 

The Investment Manager has continued to review a number of suitable investment opportunities, generated by a strong pipeline, and expects, in particular, to make qualifying investments during the coming year to ensure the Company is on course to meet its HMRC qualifying target.

 

VCT qualifying status

 

PricewaterhouseCoopers LLP ("PwC") provides the board and the Investment Manager with advice on the ongoing compliance with HMRC rules and regulations concerning VCTs and has reported no issues in this regard for the Company to date. PwC will continue to assist the Investment Manager in establishing the status of potential investments as qualifying holdings, monitoring rule compliance and maintaining the qualifying status of the Company's holdings in the future. 

 

Results

 

The Company reported a loss of £927,000 for the year, a loss of 9.19p per ordinary share (calculated on the weighted average number of shares). This is a result of the running costs of the Company exceeding its income during this initial period whilst the Company assembles suitable investments, together with the Company's listed investments portfolio being marked to market. The Net Asset Value per ordinary share ("NAV") at 28 February 2019 was 89.38p. In line with the Company's dividend policy as stated in the Prospectus, no dividend was declared in respect of this accounting year.

 

Outlook

 

The Investment Manager has a strong pipeline of companies which are suitable for investment. There are many suitable companies which are well-managed, in good market positions and which need our finance. We therefore believe the Company is well positioned to assemble a portfolio to deliver attractive returns to shareholders in the medium to long term.

 

 

 

David Buchler

Chairman

27 June 2019

INVESTMENT MANAGER'S REPORT 

 

 

Introduction

 

As set out in the Chairman's Statement, availability of finance continues to be restricted for small and medium sized businesses (SMEs). As a consequence, the Company has been able to make a number of attractive investments in smaller companies. We have also continued to see a strong pipeline of potential investments, particularly opportunities to make further qualifying investments to ensure the Company meets its HMRC qualifying target.

 

Investments

 

Qualifying Investments

 

Pure Cremation - Crematorium and Direct Cremations

In November 2018, the Company invested £1.3 million in Pure Cremation Holdings Limited (as part of a total cumulative £7.35 million qualifying investment alongside other Puma VCTs). Pure Cremation is a leading provider of so-called direct cremations, meeting the needs of a growing number of people in the United Kingdom who want a respectful direct cremation arranged without any funeral, leaving them free to say farewell how, where and when is right for them. The Pure Cremation team have many years' experience in the funeral services sector and acquired a site near Andover to develop a new crematorium and central facility. We are pleased to report that the Andover facility opened earlier this year and the business is performing well.

 

Knott End - Pubs with Microbreweries

In December 2018, the Company invested £847,000 in Knott End Pub Company Limited (as part of a total cumulative £7.3 million qualifying investment alongside other Puma VCTs). Knott End has entered into a franchise agreement with Brewhouse & Kitchen Limited to roll out a portfolio of pubs offering on-site craft micro-brewing activities and good quality food. During the period, Knott End opened its first two pubs, in Milton Keynes and Horsham, West Sussex, both of which are trading well.

 

Dymag Group - High performance wheel manufacturer

In December 2018 the Company invested £583,000 into Dymag Group Limited as part of a £3.6 million transaction, investing alongside the Puma Alpha EIS fund. Dymag is a British designer and manufacturer of carbon hybrid automotive wheels. These are light weight wheels for performance cars. Established in 1974, Dymag is a pioneer in carbon wheel technology: it launched the first commercial carbon motorcycle wheel in 1996 and the first carbon hybrid car wheel in 2004. Following Dymag's successful expansion into car wheel manufacturing, the company continues to grow its presence in the aftermarket and original equipment manufacturer (OEM) channels, working with strategic regional aftermarket partners and several of the world's leading performance OEMs.

 

Open House - London based food and beverage offer

In February 2019 the Company invested £1.8 million into Open House London Limited as part of a £5 million transaction, investing alongside the Puma Alpha EIS fund. Open House owns and operates popular dining and drinking venues in London, The Lighterman and Percy & Founders. Open House was launched in 2015 by the team behind Cubitt House, a group of highly successful gastropubs in central London that were later sold to a private equity group in a competitive acquisition. The Company's investment will support the business in achieving its plans for future growth though further flagship units across London.

 

Liquidity Management

 

To manage the Company's liquidity, £4.9 million was allocated to be invested in a portfolio of listed equities during the year. At the end of February 2019 £3.9 million had been invested in a variety of UK listed equities with the highest exposure being to mid-sized companies with a market capitalisation between £100m and £4bn. During the year the portfolio recorded an unrealised capital loss of £550,000 and provided a dividend income of £36,000 to the fund. The decline in the listed equities reflects the weakness of the UK stock market, and particularly of mid-sized UK focused companies, over the period in which the equities were invested. This particularly negatively impacted mid-sized UK focused companies due to concerns over Brexit.

 

Investment Strategy

 

We are pleased to have invested the Company's funds in a diverse range of businesses and projects. We remain focused on generating strong returns for the Company in the qualifying portfolio as well as the equities portfolio held for liquidity management purposes, whilst balancing these returns with maintaining an appropriate risk exposure.

 

The Investment Management team continues to meet with companies which are potentially suitable for investment. Over the course of the next year, the Company will build the qualifying portfolio to ensure the Company remains on course to meets its HMRC qualifying target. We have strong deal-flow and are meeting many potential investee companies with several interesting opportunities to make further qualifying investments.

 

 

Puma Investment Management Limited

27 June 2019

 

Investment Portfolio Summary

As at 28 February 2019 

 

 

Valuation

Cost

Gain/(loss)

Valuation as a % of Net Assets

£'000

£'000

£'000

Qualifying Investments

Dymag Group Limited

583

583

-

4%

Knott End Pub Company Limited

847

847

-

6%

Open House London Limited

1,800

1,800

-

13%

Pure Cremation Holdings Limited

1,297

1,297

-

10%

Total Qualifying Investments

4,527

4,527

-

33%

Liquidity Management

Barclays Plc

188

206

(18)

1%

British Land Company Plc

208

208

-

2%

Chemring Group Plc

137

188

(51)

1%

Diageo Plc

214

201

13

2%

Discoverie Group Plc

213

207

6

2%

Dixons Carphone Plc

169

207

(38)

1%

Firstgroup Plc

200

202

(2)

1%

GVC Holdings (UK) Limited

143

217

(74)

1%

Headlam Group Plc

180

197

(17)

1%

ITE Group Plc

188

211

(23)

1%

Legal & General Group Plc

216

201

15

2%

McColl's Retail Group Plc

79

197

(118)

1%

Norcros Plc

178

201

(23)

1%

Provident Financial Plc

229

226

3

2%

Prudential Plc

184

202

(18)

1%

PZ Cussons Plc

164

203

(39)

1%

Revolution Bars Limited

129

204

(75)

1%

Sports Direct International Plc

166

216

(50)

1%

Volution Group Plc

160

201

(41)

1%

Total Liquidity Management investments

3,345

3,895

(550)

24%

Total Investments

7,872

8,422

(550)

57%

Balance of Portfolio

6,057

6,057

-

43%

Net Assets

13,929

14,479

(550)

100%

 

 

 

Of the investments held at 28 February 2019, all are incorporated in England and Wales.

 

 

 

 

Income Statement

For the year ended 28 February 2019

 

 

 

 

Year ended 28 February 2019

Period ended 28 February 2018

Note

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Loss on investments

8 (b)

-

(550)

(550)

-

-

-

Income

2

45

-

45

-

-

-

45

(550)

(505)

-

-

-

Investment management fees

3

(49)

(147)

(196)

-

-

-

Other expenses

4

(200)

(26)

(226)

(8)

-

(8)

(249)

(173)

(422)

(8)

-

(8)

Loss before taxation

(204)

(723)

(927)

(8)

-

(8)

Taxation

5

-

-

-

-

-

-

Loss and total comprehensive income for the year

(204)

(723)

(927)

(8)

-

(8)

Basic and diluted

Loss per Ordinary Share (pence)

6

(2.02p)

(7.17p)

(9.19p)

n/a

n/a

n/a

 

 

 

All items in the above statement derive from continuing operations. 

 

There are no gains or losses other than those disclosed in the Income Statement.

 

The total column of this statement is the Statement of Total Comprehensive Income of the Company prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The supplementary revenue and capital columns are prepared in accordance with the Statement of Recommended Practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued in November 2014 by the Association of Investment Companies and updated in February 2018.

 

 

 

Balance Sheet

As at 28 February 2019

 

 

Note

As at28 February 2019

As at28 February 2018

£'000

£'000

Fixed Assets

Investments

8

7,872

-

Current Assets

Debtors

9

2,851

18

Cash

3,382

-

6,233

18

Creditors - amounts falling due within one year

 

10

(176)

(20)

Net Current Assets

6,057

(2)

Net Assets/(Liabilities)

13,929

(2)

Capital and Reserves

Called up share capital

12

12

6

Share premium account

14,852

-

Capital reserve - realised

(173)

-

Capital reserve - unrealised

(550)

-

Revenue reserve

(212)

(8)

Total Equity

13,929

(2)

Net Asset Value per Ordinary Share

13

89.38p

n/a

 

The financial statements on pages 26 to 41 were approved and authorised for issue by the Board of Directors on 27 June 2019 and were signed on their behalf by:

 

 

 

 

 

David Buchler

Chairman

 

Statement of Cash Flows

For the year ended 28 February 2019

 

 

 

 

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

Loss after tax

(927)

(8)

Loss on investments

550

-

Increase in debtors

(1,011)

-

Increase in creditors

110

8

Net cash used in operating activities

(1,278)

-

Cash flow from investing activities

Purchase of investments

(8,422)

-

Net cash used in investing activities

(8,422)

-

Cash flow from financing activities

Proceeds received from issue of ordinary share capital

13,759

-

Expense paid for issue of share capital

(677)

-

Net cash generated from financing activities

13,082

-

Net increase in cash and cash equivalents

3,382

-

Cash and cash equivalents at the beginning of the period

-

-

Cash and cash equivalents at the end of the period

3,382

-

 

 

 

Statement of Changes in Equity

For the year ended 28 February 2019

 

Called up share capital

Share premium account

Capital reserve - realised

Capital reserve - unrealised

Revenue reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

Balance as at 31 August 2017

4

-

-

-

-

4

Shares issued in the period

2

-

-

-

-

2

Total comprehensive income for the period

-

-

-

-

(8)

(8)

Balance as at 28 February 2018

6

-

-

-

(8)

(2)

Shares issued in the period

8

15,575

-

-

-

15,583

Expenses of share issues

-

(723)

-

-

-

(723)

Share cancelled in the period

(2)

-

-

-

-

(2)

Total comprehensive income for the year

-

-

(173)

(550)

(204)

(927)

Balance as at 28 February 2019

12

14,852

(173)

(550)

(212)

13,929

 

 

 

 

Distributable reserves comprise: Capital reserve-realised, Capital reserve-unrealised (excluding gains on unquoted investments) and the Revenue reserve. At the year end, distributable revenue reserves were nil (2018: nil).

 

The Capital reserve-realised includes gains/losses that have been realised in the year due to the sale of investments, net of related costs. The Capital reserve-unrealised represents the investment holding gains/losses and shows the gains/losses on investments still held by the Company not yet realised by an asset sale.

 

Share premium represents premium on shares issued less issue costs.

 

The revenue reserve represents the cumulative revenue earned less cumulative distributions.

1. Accounting Policies

 

 

Accounting convention

Puma VCT 13 plc ("the Company") was incorporated in England on 15 September 2016 and is registered and domiciled in England and Wales. The Company's registered number is 10376236. The registered office is Bond Street House, 14 Clifford Street, London W1S 4JU. The Company is a public limited company (limited by shares) whose shares are listed on LSE with a premium listing. The Company's principal activities and a description of the nature of the Company's operations are disclosed in the Strategic Report.

 

The financial statements have been prepared under the historical cost convention, modified to include investments at fair value, and in accordance with the requirements of the Companies Act 2006, including the provisions of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 and with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' ("FRS 102") and the Statement of Recommended Practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued in November 2014 by the Association of Investment Companies and updated in February 2018 ("the SORP").

 

The comparative period is for the six month period to 28 February 2018.

 

Monetary amounts in these financial statements are rounded to the nearest whole £1,000, except where otherwise indicated.

 

Investments

All investments are measured at fair value. They are all held as part of the Company's investment portfolio and are managed in accordance with the investment policy set out on page 9.

 

Listed investments are stated at bid price at the reporting date.

 

Unquoted investments are stated at fair value by the Directors with reference to the International Private Equity and Venture Capital Valuation Guidelines ("IPEV") as follows:

 

· Investments which have been made within the last twelve months or where the investee company is in the early stage of development will usually be valued at the price of recent investment except where the company's performance against plan is significantly different from expectations on which the investment was made, in which case a different valuation methodology will be adopted.

 

· Investments in debt instruments will usually be valued by applying a discounted cash flow methodology based on expected future returns of the investment.

 

· Alternative methods of valuation such as multiples or net asset value may be applied in specific circumstances if considered more appropriate.

 

Realised surpluses or deficits on the disposal of investments are taken to realised capital reserves, and unrealised surpluses and deficits on the revaluation of investments are taken to unrealised capital reserves.

 

Income

Dividends receivable on listed equity shares are brought into account on the ex-dividend date. Dividends receivable on unquoted equity shares are brought into account when the Company's right to receive payment is established and there is no reasonable doubt that payment will be received. Interest receivable is recognised wholly as a revenue item on an accruals basis.

 

Performance fees

Upon its inception, the Company agreed performance fees payable to the Investment Manager, Puma Investment Management Limited, and members of the investment management team at 20% of the aggregate excess of the amounts realised over £1.05 per Ordinary Share returned to Ordinary Shareholders. This incentive will only be effective once the other holders of Ordinary Shares have received distributions of £1.05 per share.

 

The performance incentive has been satisfied through the issue of 3,895,834 Ordinary Shares (as set out in note 11 of the financial statements) to the Investment Manager and members of the investment management team being 20% of the total issued Ordinary Share capital of 19,479,172 (after share cancellation on 22 March 2019 explained in note 11 of the financial statements). Under the terms of the incentive arrangement, all rights to dividends will be waived until the £1.05 per Ordinary Share performance target has been met. The performance fee is accounted for as an equity-settled share-based payment.

Section 26 of FRS 102 "Share-Based Payment" requires the recognition of an expense in respect of share-based payments in exchange for goods or services. Entities are required to measure the goods or services received at their fair value, unless that fair value cannot be estimated reliably in which case that fair value should be estimated by reference to the fair value of the equity instruments granted.

 

At each balance sheet date, the Company estimates that fair value by reference to any excess of the net asset value, adjusted for dividends paid, over £1.05 per share in issue at the balance sheet date. Any change in fair value is recognised in the Income Statement with a corresponding adjustment to equity.

 

Expenses

All expenses (inclusive of VAT) are accounted for on an accruals basis. Expenses are charged wholly to revenue, with the exception of:

 

· expenses incidental to the acquisition or disposal of an investment charged to capital; and

· the investment management fee, 75% of which has been charged to capital to reflect an element which is, in the directors' opinion, attributable to the maintenance or enhancement of the value of the Company's investments in accordance with the Board's expected long-term split of return; and

· the performance fee which is allocated proportionally to revenue and capital based on the respective contributions to the Net Asset Value.

 

Taxation

Corporation tax is applied to profits chargeable to corporation tax, if any, at the applicable rate for the year. The tax effect of different items of income/gain and expenditure/loss is allocated between capital and revenue return on the marginal basis as recommended by the SORP.

 

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more, or right to pay less, tax in the future have occurred at the balance sheet date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the financial statements which are capable of reversal in one or more subsequent periods. Deferred tax is measured on a non-discounted basis at the tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

 

Reserves

Realised losses and gains on investments, transaction costs, the capital element of the investment management fee and taxation are taken through the Income Statement and recognised in the Capital Reserve - Realised on the Balance sheet. Unrealised losses and gains on investments and the capital element of the performance fee are also taken through the Income Statement and are recognised in the Capital Reserve - Unrealised.

 

Debtors

Debtors include other debtors and accrued income which is recognised at amortised cost, equivalent to the fair value of the expected balance receivable.

 

Creditors

Creditors are initially measured at the transaction price and subsequently measured at amortised cost, being the transaction price less any amounts settled.

 

Dividends

Final dividends payable are recognised as distributions in the financial statements when the Company's liability to make payment has been established. The liability is established when the dividends proposed by the Board are approved by the Shareholders. Interim dividends are recognised when paid.

 

Key accounting estimates and assumptions

The Company makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets within the next financial year relate to the fair value of unquoted investments. Further details of the unquoted investments are disclosed in the Investment Manager's Report on pages 3 to 4 and notes 8 and 14 of the financial statements.

 

 

2. Income

 

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

Income from investments

Dividends received

36

-

36

-

Other income

Bank deposit income

9

-

45

-

 

 

 

3. Investment Management Fees

 

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

Puma Investments fees

196

-

196

-

 

 

Puma Investment Management Limited ("Puma Investments") has been appointed as the Investment Manager of the Company for an initial period of five years, which can be terminated by not less than twelve months' notice, given at any time by either party, on or after the fifth anniversary. The Board is satisfied with the performance of the Investment Manager. Under the terms of this agreement Puma Investments will be paid an annual fee of 2% of the Net Asset Value payable quarterly in arrears calculated on the relevant quarter end NAV of the Company. These fees commenced on 19 March 2018 (the date of the first share allotment). These fees are capped, the Investment Manager having agreed to reduce its fee (if necessary to nothing) to contain total annual costs (excluding performance fee and trail commission) to within 3.5% of funds raised. Total costs this year were 2.8% (2018: nil) of the funds raised. Graham Shore, a director, holds a Directorship of the parent of the Investment Manager.

 

In addition to the investment manager fees disclosed above, during the year ended 28 February 2019, Puma Investments Management Limited charged fees totalling £467,500 (2018: £nil) in relation to share issue costs. The fees were to cover the costs of launching the VCT.

 

 

4. Other expenses

 

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

PI Administration Services fees

34

-

Directors' remuneration

58

-

Social security costs

4

-

Auditor's remuneration for statutory audit

25

8

Transaction costs

26

-

Other expenses

79

-

226

8

 

 

PI Administration Services Limited provides administrative services to the Company for an aggregate annual fee of 0.35% of the Net Asset Value of the Fund, payable quarterly in arrears.

 

Remuneration for each Director for the year is disclosed in the Directors' Remuneration Report on page 16. The Company had no employees (other than Directors) during the year (2018: none). The average number of non-executive Directors during the year was 3 (2018: 3). The non-executive Directors are considered to be the Key Management Personnel of the Company with total remuneration for the year of £62,000 (2018: nil) including social security costs.

 

The Auditor's remuneration of £20,500 (2018: £6,250) has been grossed up in the table above to be inclusive of VAT.

 

 

5. Taxation

 

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

UK corporation tax charged to revenue reserve

-

-

UK corporation tax charged to capital reserve

-

-

UK corporation tax charge for the year

-

-

Factors affecting tax charge for the year

Loss before taxation

(927)

(8)

Tax charge calculated on loss before taxation at the applicable rate of 19%

(176)

(2)

Tax on capital items not taxable

105

-

Tax losses carried forward

71

2

-

-

 

 

Capital returns are not taxable as the Company is exempt from tax on realised capital gains whilst it continues to comply with the VCT regulations, so no corporation tax or deferred tax is recognised on capital gains or losses.

 

No provision for deferred tax has been made in the current accounting year. Due to the Company's status as a Venture Capital Trust and the intention to continue meeting the conditions required to obtain approval in the foreseeable future, the Company has not provided deferred tax on any capital gains and losses arising on the revaluation or disposal of investments. No deferred tax asset has been recognised in respect of the tax losses carried forward due to the uncertainty as to recovery.

 

6. Basic and diluted return/(loss) per Ordinary Share

 

Year ended 28 February 2019

Revenue

Capital

Total

Total comprehensive income for the year

(£204,000)

(£723,000)

(£927,000)

Weighted average number of shares in issue for the year

19,086,640

19,086,640

19,086,640

Less: weighted average number of management incentive shares (see note 11)

(9,000,000)

(9,000,000)

(9,000,000)

Weighted average number of shares for purposes of return/(loss) per share calculations

10,086,640

10,086,640

10,086,640

Loss per share

(2.02p)

(7.17p)

(9.19p)

 

 

No return/(loss) per share is presented for 2018 due to minimal activity in the period.

 

7. Dividends

 

The Directors will not propose a resolution at the Annual General Meeting to pay a final dividend (2018: nil).

 

 

8. Investments

 

(a) Movements in investments

Qualifying investments

Non-qualifying investments

Total

£'000

£'000

£'000

Purchased at cost

-

-

-

Net unrealised gains/(losses)

-

-

-

Valuation at 1 March 2018

-

-

-

Purchases at cost

4,527

3,895

8,422

Net unrealised losses

-

(550)

(550)

Valuation at 28 February 2019

4,527

3,345

7,872

Book cost at 28 February 2019

4,527

3,895

8,422

Net unrealised losses at 28 February 2019

-

(550)

(550)

Valuation at 28 February 2019

4,527

3,345

7,872

(b) Losses on investments

Year ended 28 February 2019

Period ended 28 February 2018

£'000

£'000

Realised gains on investment

-

-

Unrealised losses in period

(550)

-

(550)

-

(c) Quoted and unquoted investments

Market value as at 28 February 2019

Market value as at 28 February 2018

£'000

£'000

Quoted investments

3,345

-

Unquoted investments

4,527

-

7,872

-

 

 

Further details of these investments (including the unrealised loss in the year) are disclosed in the Chairman's Statement, Investment Manager's Report, Investment Portfolio Summary and Significant Investments on pages 1 to 7 of the Annual Report.

 

 

9. Debtors

 

As at 28 February 2019

As at 28 February 2018

£'000

£'000

Other debtors

2,829

18

Prepayments and accrued income

22

-

2,851

18

 

Other debtors includes cash held by the company share registrar of £1,824,000 (2018: £nil) and cash held by the company's brokers of £1,005,000 (2018: £nil).

 

 

10. Creditors - amounts falling due within one year

 

As at 28 February 2019

As at 28 February 2018

£'000

£'000

Accruals

163

7

Redeemable preference shares

13

13

176

20

 

Redeemable preference shares were issued for total consideration £12,500 to Puma Investment Management Limited, being one quarter paid up, so as to enable the Company to obtain a certificate under s.761 of the Companies Act 2006.

 

Each of the redeemable preference shares carries the right to a fixed, cumulative, preferential dividend of 0.1% per annum (exclusive of any imputed tax credit available to shareholders) on the nominal amount thereof but confers no right to vote except as otherwise agreed by the holders of a majority of the Shares. On a winding-up, the redeemable preference shares confer the right to be paid the nominal amount paid on such shares. The redeemable preference shares are redeemable at any time by the Company and by the holder. Each redeemable preference share which is redeemed, shall, thereafter be cancelled without further resolution or consent.

 

 

11. Management Performance Incentive Arrangement

 

On 8 December 2016, the Company entered into an Agreement with the Investment Manager and members of the investment management team (together "the Management Team") such that the Management Team will be entitled in aggregate to share in 20 per cent of the aggregate excess on any amounts realised by the Company in excess of £1.05 per Ordinary Share, the Performance Target. This agreement was amended by a deed of variation on 28 June 2018 to extend the terms to cover the extended fundraising period.

 

This incentive is effective through the issue of ordinary shares in the Company, such that the Management Team hold 3,895,834 ordinary shares being 20% of the issued share capital of 19,479,172. As at 28 February 2019, there were 7,500,000 ordinary shares held by the Management Team. This was reduced to 3,895,834 ordinary shares on 22 March 2019 by the cancellation of 3,604,166 ordinary shares in accordance with the Terms of the Agreement.

 

The Management Team will waive all rights to dividends until a return of £1.05 per share (whether capital or income) has been paid to the other shareholders.

 

The performance incentive structure provides a strong incentive for the Investment Manager to ensure that the Company performs well, enabling the Board to approve distributions as high and as soon as possible.

 

 

12. Called Up Share Capital

 

As at 28 February 2019

As at 28 February 2018

As at 28 February 2019

As at 28 February 2018

£'000

£'000

Number of shares

Number of shares

Allotted, called up and fully paid:

Ordinary shares of 0.05p each

12

6

23,083,338

11,250,002

Allotted, called up and partly paid:

Redeemable preference shares of £1 each

13

13

50,000

50,000

 

 

Between 19 March and 5 April 2018, 8,849,391 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £8,849,391.

 

On 29 June 2018, 1,557,169 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £1,557,169.

 

On 10 October 2018, 1,839,123 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £1,839,123.

 

On 26 October 2018, 147,780 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £147,780.

 

On 11 December 2018, 779,917 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £779,917.

 

On 17 January 2019, 577,185 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £577,185.

 

On 22 February 2019, 1,832,771 Ordinary shares of £0.0005 each were allotted and issued £1 per share for total consideration of £1,832,771.

 

On 25 July 2018, 3,750,000 Ordinary shares of £0.0005 each were cancelled (during the year).

 

On 22 March 2019, 3,604,166 Ordinary shares of £0.0005 each were cancelled (post year-end).

 

 

13. Net Asset Value per Ordinary Share

As at28 February 2019

 

As at28 February 2018

 

Net assets/(liabilities)

£ 13,929,000

£ (2,000)

Number of shares in issue

23,083,338

11,250,002

Less: management incentive shares (see note 11)

(7,500,000)

(11,250,000)

Number of shares in issue for purposes of Net

Asset Value per share calculation

15,583,338

2

Net asset value per share

Basic

89.38p

n/a

Diluted

89.38p

n/a

 

 

14. Financial Instruments

 

The Company's financial instruments comprise its investments, cash balances, debtors and certain creditors. The fair value of all of the Company's financial assets and liabilities is represented by the carrying value in the Balance Sheet. Excluding cash balances, the Company held the following categories of financial instruments at 28 February 2019:

 

As at 28 February 2019

As at 28 February 2018

£'000

£'000

Financial assets at fair value through profit or loss

7,872

-

Financial assets that are debt instruments measured at amortised cost

2,838

18

Financial liabilities measured at amortised cost

(176)

(20)

10,534

(2)

 

Management of risk

The main risks the Company faces from its financial instruments are market price risk, being the risk that the value of investment holdings will fluctuate as a result of changes in market prices caused by factors other than interest rate or currency movements, liquidity risk, credit risk and interest rate risk. The Board regularly reviews and agrees policies for managing each of these risks. The Board's policies for managing these risks are summarised below and have been applied throughout the year.

 

Credit risk

Credit risk is the risk that the counterparty to a financial instrument will fail to discharge an obligation or commitment that it has entered into with the Company. The Investment Manager monitors counterparty risk on an ongoing basis. The Company's maximum exposure to credit risk is as follows:

 

As at 28 February 2019

As at 28 February 2018

£'000

£'000

Cash at bank and in hand

3,382

-

Interest, dividends and other receivables

2,838

18

6,220

18

 

The cash held by the Company at the year-end is held in two U.K. banks. Bankruptcy or insolvency of the bank may cause the Company's rights with respect to the receipt of cash held to be delayed or limited. The Board monitors the Company's risk by reviewing regularly the financial position of the bank and should it deteriorate significantly the Investment Manager will, on instruction of the Board, move the cash holdings to another bank.

 

Credit risk associated with interest, dividends and other receivables are predominantly covered by the investment management procedures. Other receivables is primary cash held by the share registrar, which has been remitted to the company since year end, and cash at the company's brokers, that is subject to reviews consistent with the banks noted above.

 

Market price risk

Market price risk arises mainly from uncertainty about future prices of financial instruments held by the Company. It represents the potential loss the Company might suffer through holding investments in the face of price movements. The Investment Manager actively monitors market prices and reports to the Board, which meets regularly in order to consider investment strategy.

 

The Company's strategy on the management of market price risk is driven by the Company's investment policy as outlined in the Strategic Report on page 9. The management of market price risk is part of the investment management process. The portfolio is managed with an awareness of the effects of adverse price movements through detailed and continuing analysis, with an objective of maximising overall returns to shareholders.

 

Holdings in unquoted investments may pose higher price risk than quoted investments. Some of that risk can be mitigated by close involvement with the management of the investee companies along with review of their trading results.

 

42% (2018: 0%) of the Company's investments are quoted investments and 58% (2018: 0%) are unquoted investments.

 

Liquidity risk

Details of the Company's unquoted investments are provided in the Investment Portfolio summary on page 5. By their nature, unquoted investments may not be readily realisable and the Board considers exit strategies for these investments throughout the period for which they are held. As at the year end, the Company had no borrowings.

 

The Company's liquidity risk associated with investments is managed on an ongoing basis by the Investment Manager in conjunction with the Directors and in accordance with policies and procedures in place as described in the Report of the Directors and the Strategic Report. The Company's overall liquidity risks are monitored on a quarterly basis by the Board. The Company maintains access to sufficient cash resources to pay accounts payable and accrued expenses.

 

Fair value interest rate risk

The benchmark that determines the interest paid or received on the current account is the Bank of England base rate, which was 0.75% at 28 February 2019 (2018: 0.5%).

 

Cash flow interest rate risk

The Company has exposure to interest rate movements primarily through its cash deposits which track either the Bank of England base rate or LIBOR.

 

Interest rate risk profile of financial assets

The following analysis sets out the interest rate risk of the Company's financial assets as at 28 February 2019.

Rate status

Average interest rate

Period until maturity

Total

£'000

Cash at bank - Metro

Floating

0.10%

-

6

Cash at bank - RBS

Floating

0.25%

-

3,376

Balance of assets

Non-interest bearing

-

10,710

14,092

Foreign currency risk

The reporting currency of the Company is Sterling. The Company has not held any non-Sterling investments during the year.

 

 

Fair value hierarchy

Financial assets and liabilities measured at fair value are disclosed using a fair value hierarchy that reflects the significance of the inputs used in making the fair value measurements, as follows:-

· Level 1 - Fair value is measured using the unadjusted quoted price in an active market for identical assets.

· Level 2 - Fair value is measured using inputs other than quoted prices that are observable using market data.

· Level 3 - Fair value is measured using unobservable inputs.

 

Fair values have been measured at the end of the reporting year as follows:-

 

2019

2018

£'000

£'000

Level 1

Investments listed on LSE

3,345

-

Level 3

Unquoted investments

4,527

-

7,872

-

 

 

The Level 3 investments have been valued in line with the Company's accounting policies and IPEV guidelines. Further details of these investments are provided in the Significant Investments section of the Annual Report on pages 6 to 7.

 

 

15. Capital management

The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern, so that it can provide an adequate return to shareholders by allocating its capital to assets commensurate with the level of risk.

By its nature, the Company must have an amount of capital, at least 70% (as measured under the tax legislation) of which must be, and remain, invested in the relatively high risk asset class of small UK companies within three years of that capital being subscribed. For accounting periods commencing after 5 April 2019 this increases to 80%.

The Company accordingly has limited scope to manage its capital structure in the light of changes in economic conditions and the risk characteristics of the underlying assets. Subject to this overall constraint upon changing the capital structure, the Company may adjust the amount of dividends paid to shareholders, issue new shares, or sell assets to maintain a level of liquidity to remain a going concern.

The Board has the opportunity to consider levels of gearing, however there are no current plans to do so. It regards the net assets of the Company as the Company's capital, as the level of liabilities is small, and the management of those liabilities is not directly related to managing the return to shareholders.

 

 

16. Contingencies, Guarantees and Financial Commitments

 

There were no commitments, contingencies or guarantees of the Company at the year-end (2018: none).

 

 

17. Controlling Party

 

In the opinion of the Directors there is no immediate or ultimate controlling party.

 

The financial information set out in this announcement does not constitute the Company's statutory financial statements in accordance with section 434 Companies Act 2006 for the year ended 28 February 2019, but has been extracted from the statutory financial statements for the year ended 28 February 2019 which were approved by the Board of Directors on 27 June 2019 and will be delivered to the Registrar of Companies. The Independent Auditor's Report on those financial statements was unqualified and did not contain any emphasis of matter nor statements under s 498(2) and (3) of the Companies Act 2006.

 

The statutory accounts for the year ended 28 February 2018 have been delivered to the Registrar of Companies and received an Independent Auditors report which was unqualified and did not contain any emphasis of matter nor statements under s 498(2) and (3) of the Companies Act 2006.

 

Copies of the full annual report and financial statements for the year ended 28 February 2019 will be available to the public at the registered office of the Company at Bond Street House, 14 Clifford Street, London, W1S 4JU and will be available for download from www.pumainvestments.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR EANKPAALNEEF
Date   Source Headline
3rd Apr 20241:41 pmRNSIssue of Equity
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20241:44 pmRNSIssue of Equity
18th Mar 20242:17 pmRNSIssue of Equity
12th Mar 20242:02 pmRNSIssue of Supplementary Prospectus
27th Feb 202412:46 pmRNSNet Asset Value(s)
31st Jan 20243:19 pmRNSIssue of Equity and Total Voting Rights
25th Jan 202411:10 amRNSPortfolio Update
18th Jan 20242:19 pmRNSIssue of Equity
4th Jan 202410:57 amRNSPortfolio Update
29th Dec 202310:14 amRNSTotal Voting Rights
11th Dec 202312:55 pmRNSIssue of Equity
30th Nov 20234:52 pmRNSTotal Voting Rights
16th Nov 20234:22 pmRNSIssue of Equity
10th Nov 202311:39 amRNSHalf-year Report
19th Oct 20232:27 pmRNSPortfolio Update
28th Sep 20236:07 pmRNSPortfolio Update
19th Sep 202311:07 amRNSOffer for Subscription
11th Sep 202311:18 amRNSIntention to Fundraise
27th Jul 20235:35 pmRNSResult of GM
27th Jul 20235:32 pmRNSResult of AGM
3rd Jul 202312:30 pmRNSAnnual Report and Notice of AGM
30th Jun 20234:35 pmRNSTotal Voting Rights
15th Jun 20232:45 pmRNSPublication of a Circular
15th Jun 20232:17 pmRNSAnnual Financial Report
7th Jun 20235:35 pmRNSIssue of Equity
5th Apr 20236:02 pmRNSIssue of Equity
4th Apr 202312:19 pmRNSIssue of Equity
3rd Apr 202310:47 amRNSOffer for Subscription Update
31st Mar 20235:54 pmRNSTotal Voting Rights
28th Mar 20234:17 pmRNSIssue of Equity
16th Mar 20235:34 pmRNSIssue of Equity
15th Mar 20237:30 amRNSOffer for Subscription – Over-Allotment Facility
2nd Mar 20236:08 pmRNSNet Asset Value
31st Jan 20234:20 pmRNSIssue of Equity and Total Voting Rights
16th Jan 20235:14 pmRNSIssue of Equity
7th Dec 20225:20 pmRNSIssue of Equity
29th Nov 20225:42 pmRNSHalf-year Report
2nd Nov 20225:50 pmRNSTotal Voting Rights – Replacement announcement
2nd Nov 202211:57 amRNSIssue of Equity – Replacement announcement
31st Oct 20224:42 pmRNSTotal Voting Rights
31st Oct 20224:40 pmRNSIssue of Equity
20th Oct 20225:21 pmRNSNet Asset Value(s)
20th Sep 20225:40 pmRNSDividend Declaration
11th Aug 20223:33 pmRNSOffer for Subscription
1st Aug 202210:25 amRNSIntention to Fundraise
7th Jul 20223:07 pmRNSResult of AGM
31st May 20225:03 pmRNSAnnual Financial Report and Notice of AGM
31st May 20225:02 pmRNSTotal Voting Rights
25th May 20224:32 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.